Ellen M Apperloo, Hiddo J L Heerspink, Annemarie B van der Aart, Dennis Rouw, Daniël H van Raalte, Klaas Hoogenberg, Niels Jongs, Marcel H A Muskiet
{"title":"探索2型糖尿病和慢性肾病患者对达格列净、艾塞那肽及其联合用药的肾氧合反应:一项预先指定的随机交叉试验先导研究的观察结果","authors":"Ellen M Apperloo, Hiddo J L Heerspink, Annemarie B van der Aart, Dennis Rouw, Daniël H van Raalte, Klaas Hoogenberg, Niels Jongs, Marcel H A Muskiet","doi":"10.2337/dc24-2244","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":93979,"journal":{"name":"Diabetes care","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2025-01-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Exploring Kidney Oxygenation Responses to Dapagliflozin, Exenatide, and Their Combination in Patients With Type 2 Diabetes and Chronic Kidney Disease: Observations From a Prespecified Pilot Study of a Randomized Crossover Trial.\",\"authors\":\"Ellen M Apperloo, Hiddo J L Heerspink, Annemarie B van der Aart, Dennis Rouw, Daniël H van Raalte, Klaas Hoogenberg, Niels Jongs, Marcel H A Muskiet\",\"doi\":\"10.2337/dc24-2244\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":93979,\"journal\":{\"name\":\"Diabetes care\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2025-01-10\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Diabetes care\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.2337/dc24-2244\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Diabetes care","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2337/dc24-2244","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Exploring Kidney Oxygenation Responses to Dapagliflozin, Exenatide, and Their Combination in Patients With Type 2 Diabetes and Chronic Kidney Disease: Observations From a Prespecified Pilot Study of a Randomized Crossover Trial.